Postmenopausal osteoporosis, breast cancer, and aromatase inhibitor

被引：3
|
作者：
Wiwanitkit, Somsri
Wiwanitkit, Viroj [1 ,2 ]
机构：
[1] Univ Nis, Fac Med, Nish, Serbia
[2] Joseph Ayobabalola Univ, Ikeji Arakeji, Nigeria
来源：
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA | 2013年 / 59卷 / 03期
关键词：
D O I：
10.1016/j.ramb.2012.12.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：217 / 217
页数：1
相关论文
共 50 条
  • [1] Which is the best aromatase inhibitor for postmenopausal breast cancer?
    Drugs & Therapy Perspectives, 2000, 16 (8) : 5 - 7
  • [2] Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
    Hadji, Peyman
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 69 (01) : 73 - 82
  • [3] Erratum to: Which is the best aromatase inhibitor for postmenopausal breast cancer?
    Drugs & Therapy Perspectives, 2001, 17 (6) : 15 - 15
  • [4] Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
    Gnant, Michael
    Fitzal, Florian
    Rinnerthaler, Gabriel
    Steger, Guenther G.
    Greil-Ressler, Sigrun
    Balic, Marija
    Heck, Dietmar
    Jakesz, Raimund
    Thaler, Josef
    Egle, Daniel
    Manfreda, Diether
    Bjelic-Radisic, Vesna
    Wieder, Ursula
    Singer, Christian F.
    Melbinger-Zeinitzer, Elisabeth
    Haslbauer, Ferdinand
    Sevelda, Paul
    Trapl, Harald
    Wette, Viktor
    Wimmer, Kerstin
    Gampenrieder, Simon P.
    Bartsch, Rupert
    Kacerovsky-Strobl, Stephanie
    Suppan, Christoph
    Brunner, Christine
    Deutschmann, Christine
    Soelkner, Lidija
    Fesl, Christian
    Greil, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (05): : 395 - 405
  • [5] Saving the bones in breast cancer: aromatase inhibitor-induced osteoporosis
    Agrawal, Neeraj Kumar
    Prakash, Ved
    Singh, Kiran
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (04) : 311 - 313
  • [6] Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women
    Kao, YC
    Okubo, T
    Sun, XZ
    Chen, S
    ANTICANCER RESEARCH, 1999, 19 (3A) : 2049 - 2056
  • [7] Screening for Osteoporosis in Postmenopausal Women With Breast Cancer Receiving Aromatase Inhibitors: Less Is More?
    Dhesy-Thind, Sukhbinder K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (13) : 1408 - 1410
  • [8] Adjuvant Aromatase Inhibitor Options in Overweight and Obese Postmenopausal Women with Breast Cancer
    Chlebowski, Rowan T.
    BREAST JOURNAL, 2013, 19 (05): : 552 - 554
  • [9] Prevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: Rationale and design of a randomized controlled trial
    Kilbreath, Sharon
    Refshauge, Kathryn M.
    Beith, Jane
    Ward, Leigh
    Sawkins, Kate
    Paterson, Ross
    Clifton-Bligh, Philip
    Sambrook, Philip N.
    Simpson, Judy M.
    Nery, Liza
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (05) : 704 - 709
  • [10] Association of adjuvant aromatase inhibitor with cataract risk in postmenopausal women with breast cancer
    Chen, Han
    Shao, Zhi-Ming
    Yu, Ke-Da
    Xu, Ge-Zhi
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
12345